It's important to understand Methadone and its place in treating addiction.
Methadone is a full agonist that can be used to help stabilize the brain and control cravings.
What is Methadone and is it right for me?
Although BrightView is not a Methadone treatment center, many of our patients have previously attended treatment programs where it was prescribed. It is generally recommended that once a patient has started a Methadone program, they should continue on the medication for at least one year. It should not be abruptly stopped as that may result in severe withdrawal symptoms. When patients transfer to a BrightView addiction treatment center from Methadone treatment centers, they are medically assessed and transitioned to another medication option under the supervision of a waivered doctor.
Methadone is a full agonist and comes in pill, wafer, and liquid forms. According to the Ohio Administrative Code, it is required to be administered in only oral, liquid doses. The Substance Abuse and Mental Health Services Administration notes that a dose of Methadone lasts only 4 to 8 hours, meaning that it must be taken more frequently than longer lasting medications like buprenorphine. All full agonists (ex. Methadone) and partial agonists (ex. buprenorphine) should only be taken as prescribed.
At BrightView, we do our best to work around the busy schedules and many commitments of our patients, which is why we prefer medications like Suboxone and Vivitrol when appropriate. The Ohio Administrative Code as of Sept. 2019 requires that patients on a Methadone treatment plan are given their dose by a licensed provider daily, receiving a maximum of one dose to take-home on holidays or Sundays, if the clinic is closed.
Any addiction treatment medications should only be prescribed and taken within the context of a comprehensive treatment plan. The medication provides neurological stability to minimize cravings, while individual and group therapy help the patient begin healing. Social support and other wraparound services are crucial to long-term recovery.
BrightView by the Numbers
According to patients reporting in anonymous surveys, more than 90% reported that BrightView’s programs are working for them. After 30 days in the program, less than 1% feel that BrightView is not working for them.
For patients in withdrawal, our average time to appropriate Medication Assisted Treatment (usually buprenorphine) and completion of the first counseling session is less than 4 hours from walking in the door.
The quality of our patients’ experience, proves that we respect them and treat each patient as an individual. When surveyed, our patients consistently rate their experience a 9 out of 10.